Zomato CEO and Eternal founder Deepinder Goyal has taken a bold step into the world of biological research with the announcement of a $25 million (INR 219.5 crore) personal seed fund for his ambitious initiative, Continue Research. The project is focused on advancing human aging and systems biology, aiming to uncover fundamental biological insights that could extend healthy human lifespan and transform the way we understand aging.
In a recent LinkedIn post, Goyal shared that the new fund is entirely self-financed and is meant to empower researchers worldwide who are willing to explore “simpler questions” that could lead to groundbreaking discoveries.
Read Also :- Naina Avtr: India’s Virtual Superstar Influencer Changing Digital World
“Today, we are expanding Continue Research to include a $25 Mn fund (entirely personally backed) to support researchers across the world who dare to ask simpler questions than anyone else,” Goyal wrote.
Table of Contents
ToggleFounded in 2023, Continue Research began as a small, internal initiative within Goyal’s ecosystem of ventures. Its primary goal was to investigate the leverage points within the human body—specific biological mechanisms that could influence the rate of aging and overall longevity. What started as a curiosity-driven project has now evolved into a global research effort supported by one of India’s most influential entrepreneurs.
Goyal hinted that his team has been exploring what he calls a “penny-drop insight” about human aging—something obvious yet overlooked by mainstream science. He believes this revelation could be key to unlocking new pathways in longevity science, improving both lifespan and quality of life.
Unlike traditional tech or startup investments, Goyal’s initiative dives deep into fundamental biology, emphasizing the need for upstream research—the stage of science that happens long before commercial applications emerge. Continue Research aims to understand the biology of aging at its core and contribute to what Goyal describes as “conscious evolution”—a process of enhancing human potential and extending healthy living through scientific advancement.
“The goal of Continue Research is to understand biology more deeply and contribute toward conscious evolution, extending healthy human lifespan and function over time,” Goyal explained in his post.
With the new $25 million fund, Continue Research plans to support scientists, biologists, and research teams globally who are challenging conventional scientific thinking. By funding curiosity-driven experiments, the initiative hopes to fill a crucial gap in scientific funding—where groundbreaking ideas often struggle to find early financial support.
This move also marks a shift in how India’s entrepreneurial leaders are engaging with deep science and long-term research. Goyal joins a growing list of tech founders who are channeling personal wealth into biotech, longevity, and health innovation, positioning India as an emerging hub for future-focused research.
Deepinder Goyal’s venture into biological research represents more than just philanthropy—it’s a commitment to human progress. With Continue Research, he aims to blur the lines between technology, biology, and evolution itself. As the world faces an aging population and rising health challenges, initiatives like this could redefine how we think about life, health, and longevity in the decades to come.